Chemomab to Present at Oppenheimer s Virtual Rare and Orphan Disease Summit
USA - English
Share this article
Share this article
TEL AVIV, Israel, May 12, 2021 /PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced that the company s CEO, Dr. Adi Mor will present a corporate update at Oppenheimer s virtual Rare and Orphan Disease Summit on May 21
st, 2021.
Webcast link may be accessed here.
The presentation will be available for 30 days following the event on the Company s investors section at the Chemomab website.
Share this article
Share this article
TEL-AVIV, Israel, April 26, 2021 /PRNewswire/ Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced enrollment of the first patient in its Phase 2a study of CM-101 in Non-Alcoholic Steatohepatitis (NASH). CM-101 is a first-in-class humanized monoclonal antibody designed to bind to and block CCL24 activity, an important chemokine activity that stimulates inflammation and the development of fibrosis.
The Phase 2a study is a multi-center, randomized, double-blind, placebo-controlled, multiple dose study designed to assess the mechanism of action, safety, pharmacokinetics and pharmacodynamic effects, as well as the anti-fibrotic effects of subcutaneous CM-101 in NASH patients with fibrosis stage F2-F3. The trial will enroll 40 patients and is anticipated to complete enrollment by the end
A Burnham-On-Sea widow has teamed up with a local artist to launch a unique image of Burnham’s lighthouse in her husband’s memory and to raise funds for two very special causes.
As reported a year ago here, Amy Bridgewater’s husband, Andrew Bridgewater sadly passed away at the age of 36 after suffering heart failure.
Now, Amy and a local artist have launched digital Lino prints of Burnham’s iconic beach lighthouse, pictured here. The landmark had a special meaning to the couple.
She says: “In memory of Andrew and with a wish to help those who have likely suffered even more as a result of the pandemic, in the absence of being able to meet and raise money in person, I wanted to recognise and say thank you to the people who had supported and helped Andrew through his illnesses.”
Chemomab Completes Merger with Anchiano Therapeutics
USA - English
Combined company will focus on advancing Chemomab s CM-101 currently in Phase 2 for rare fibrotic indications
Company to receive gross proceeds of $45.5 Million from a PIPE financing, led by healthcare-focused investors Cormorant Asset Management, OrbiMed, Peter Thiel and Christian Angermayer s Presight Capital and Apeiron Investment Group
News provided by
Share this article
Share this article
TEL-AVIV, Israel, March. 16, 2021 /PRNewswire/ Chemomab Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced the completion of its merger with Anchiano Therapeutics Ltd. ( Anchiano ).
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45 5M Private Financing forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.